While tirzepatide does not directly affect thyroid function, the caloric deficit it produces creates similar metabolic pressure
NICE guidance on obesity management (CG189) emphasises evidence-based interventions including dietary modification, increased physical activity, behavioural therapy, andwhere appropriatepharmacotherapy with licensed medications such as orlistat or semaglutide (NICE TA875)
For sub-cut , a 30G x 1/2 inch is best -really fine
Additional support For details about your medication and dosing, please log in to your patient portal
Can AOD-9604 be combined with GLP-1 peptides like semaglutide or tirzepatide
Long-term follow-up studies indicate that women maintain 60-70% of their fat loss gains at 6 months post-treatment, particularly when combined with lifestyle modifications established during the peptide cycle